A Study to Evaluate the Co-Administration of MK-4618 With Antihypertensive Agents
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Vibegron (Primary) ; Amlodipine; Metoprolol
- Indications Hypertension; Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 06 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 06 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.